Skip to main navigation Skip to search Skip to main content

A Multicenter, Randomized, Parrallel-Group, Double-Blind, Placebo-Controlled Study of Combination Thalidomide Plus Dexamethasone Therapy Versus Dexamethasone Therapy Alone as Induction Therapy for Previously Untreated Subjects with Multiple

Project: Research

Project Details

StatusFinished
Effective start/end date03/20/03 → 12/31/07

Funding

  • Celgene Corporation: $8,490.00